← Evidence map

TrialFrontiers in immunology2024

Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5-11 years: a phase 2/3, randomized, active-controlled study.

Rino Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39286253